AP2003002737A0 - Tartrate salts of thiazolidinedione derivatives - Google Patents

Tartrate salts of thiazolidinedione derivatives

Info

Publication number
AP2003002737A0
AP2003002737A0 APAP/P/2003/002737A AP2003002737A AP2003002737A0 AP 2003002737 A0 AP2003002737 A0 AP 2003002737A0 AP 2003002737 A AP2003002737 A AP 2003002737A AP 2003002737 A0 AP2003002737 A0 AP 2003002737A0
Authority
AP
ARIPO
Prior art keywords
compound
tartrate salts
thiazolidinedione derivatives
tartrate
thiazolidinedione
Prior art date
Application number
APAP/P/2003/002737A
Other languages
English (en)
Inventor
Andrew Simon Craig
Tim Chien Ting Ho
Michael John Millan
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of AP2003002737A0 publication Critical patent/AP2003002737A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cosmetics (AREA)
APAP/P/2003/002737A 2000-08-04 2001-08-03 Tartrate salts of thiazolidinedione derivatives AP2003002737A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0019226.0A GB0019226D0 (en) 2000-08-04 2000-08-04 Novel pharmaceutical
PCT/GB2001/003514 WO2002012233A1 (en) 2000-08-04 2001-08-03 Tartrate salts of thiazolidinedione derivative

Publications (1)

Publication Number Publication Date
AP2003002737A0 true AP2003002737A0 (en) 2003-03-31

Family

ID=9897028

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/2003/002737A AP2003002737A0 (en) 2000-08-04 2001-08-03 Tartrate salts of thiazolidinedione derivatives

Country Status (23)

Country Link
EP (1) EP1307448A1 (ja)
JP (1) JP2004505971A (ja)
KR (1) KR20030022356A (ja)
CN (1) CN1458930A (ja)
AP (1) AP2003002737A0 (ja)
AU (1) AU2001276508A1 (ja)
BG (1) BG107605A (ja)
BR (1) BR0112984A (ja)
CA (1) CA2417828A1 (ja)
CZ (1) CZ2003314A3 (ja)
EA (1) EA200300231A1 (ja)
EC (1) ECSP034468A (ja)
GB (1) GB0019226D0 (ja)
HU (1) HUP0300770A2 (ja)
IL (1) IL154277A0 (ja)
MA (1) MA25830A1 (ja)
MX (1) MXPA03001086A (ja)
NO (1) NO20030508L (ja)
OA (1) OA12355A (ja)
PL (1) PL360702A1 (ja)
SK (1) SK1452003A3 (ja)
WO (1) WO2002012233A1 (ja)
ZA (1) ZA200300962B (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39384E1 (en) 1993-09-01 2006-11-07 Smithkline Beecham P.L.C. Substituted thiazolidinedione derivatives
FR2845602B1 (fr) * 2002-10-11 2005-07-08 Servier Lab Association entre un ligand des recepteurs actives par les proliferateurs de peroxisomes et un agent antioxydant et les compositions pharmaceutiques qui les contiennent
US7264813B2 (en) 2003-09-24 2007-09-04 Nikken Sohonsha Corporation Therapeutic uses of Dunaliella powder
CN102532122B (zh) * 2010-12-29 2015-12-02 开封制药(集团)有限公司 酒石酸罗格列酮的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds

Also Published As

Publication number Publication date
MA25830A1 (fr) 2003-07-01
KR20030022356A (ko) 2003-03-15
ZA200300962B (en) 2003-10-29
NO20030508L (no) 2003-03-20
BG107605A (bg) 2003-09-30
CN1458930A (zh) 2003-11-26
EP1307448A1 (en) 2003-05-07
GB0019226D0 (en) 2000-09-27
WO2002012233A1 (en) 2002-02-14
AU2001276508A1 (en) 2002-02-18
CZ2003314A3 (cs) 2004-02-18
MXPA03001086A (es) 2003-05-27
EA200300231A1 (ru) 2003-06-26
OA12355A (en) 2004-03-19
HUP0300770A2 (hu) 2003-11-28
CA2417828A1 (en) 2002-02-14
ECSP034468A (es) 2003-03-31
JP2004505971A (ja) 2004-02-26
IL154277A0 (en) 2003-09-17
PL360702A1 (en) 2004-09-20
BR0112984A (pt) 2003-06-10
NO20030508D0 (no) 2003-01-31
SK1452003A3 (en) 2004-05-04

Similar Documents

Publication Publication Date Title
AP1545A (en) Hydrochloride salts of 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione.
CY1105252T1 (el) Το υδροχλωρικο αλας της 5-[4-[2-(ν-μεθυλο-ν-(2-πυριδυλο)αμινο)-αιθοξυ]βενζυλο]θειαζολιδινο-2,4-διονης
AP1814A (en) Tartrate salts of thiazolidinedione derivative.
CY1105354T1 (el) Ένα παραγωγο θειαζολιδινοδιονης και η χρηση του σαν αντι-διαβητικο
AP2003002737A0 (en) Tartrate salts of thiazolidinedione derivatives
AP1562A (en) Thiazolidinedione derivatives and its use as antidiabetic.
PT1349855E (pt) Sal misilato de 5-{4-[2-(n-metil-n-(2-piridil)amino)etoxi]benzil}tiazolidino-2, 4-diona
AP1785A (en) Tartrate salt of thiazolidinedione derivative.
AU2002343052A1 (en) Rosiglitazone edisylates and their use as antidiabetics
MXPA02012100A (es) Sal de tiazodilindiona para el tratamiento de la diabetes mellitus.
AP1680A (en) Thiazolidinedione derivative and its use as antidiabetic.
AP1813A (en) Tartrate salts of thiazolidinedione derivative.
HK1057204A1 (en) A thiazolidinedione derivative and its use as antidiabetic
AP2002002684A0 (en) 5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2-pyridyl) amino) ethoxy)benzyl) thiazolidine-2,4-dione hydriodide as pharmaceutical
AP1738A (en) Sodium salts of 5-[4-[2-(N-Methyl -N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione.
AP1841A (en) A thiazolidinedione derivative and its use as antidiabetic.
EP1867343A3 (en) Inclusion complexes of a cyclodextrin with a thiazolidine-2,4-dione
HK1068884A1 (en) 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyleof; and its use as pharmaceutical active ingredie)thiazolidine-2,4-dione benzenesulfonate; process for its preparation; polymorphs i, ii and iii thernt
ECSP003434A (es) Nuevos compuestos